Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-27

FDA Approved: EVAMIST — Original Application (Padagis US LLC)

View source ↗

Summary

The FDA approves Evamist (estradiol) from Padagis US LLC under NDA 022014 for the treatment of vasomotor symptoms associated with menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVAMIST (ESTRADIOL)

Snippet

ORIG AP for EVAMIST (ESTRADIOL)